Evaluation of Persistence of Immunity in 4-year-old Children Previously Immunised With IPV-Al AJV (Picovax®)
NCT04448132
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
163
Enrollment
INDUSTRY
Sponsor class
Conditions
Poliomyelitis
Interventions
BIOLOGICAL:
IPV-Al
Sponsor
AJ Vaccines A/S